Loading...

MBOT MICROBOT MEDICAL INC Management Changes 8-K Filing

MCRB

MBT

MICROBOT MEDICAL INC

(MBOT)

2026 8-K

Robotic Procedure Success

Research Publication Update

Conference Announcement

Conference Announcement

AMA Support Announcement

Operational Stability Confi...

Management Changes

New Hospital Adoption

Product Showcase

Conference Attendance

2026 Milestones Announced

New Medical Adoption

Product Launch Announcement

Product Exhibition

Partnership Announcement

Equity Sale Notification

Investment Options Exercised

CEO Interview Announcement

Executive Bonuses Granted

Equity Agreement Update

Investor Conference Update

FDA Clearance Announcement

Stock Options Exercise

Stock Options Exercised

Management Changes

Equity Offerings

Equity Offerings

Equity Offerings

Equity Offerings

Product Expansion

Market Expansion

Presentation Materials

Equity Offerings

Annual Meeting Update

By-law Amendment

Trial Data Announcement

Management Change

Research Collaboration

Capital Raise Update

Management Changes

Conference Announcement

Nasdaq Compliance

CEO Bonus Approval

Management Appointment

Commercial Launch Prep

Director Appointment

Presentation Update

Clinical Trial Update

Nasdaq Compliance Notice

Clinical Trial Update

Clinical Trial Update

Presentation Update

Collaboration Agreement

ISO Certification

Collaboration Agreement

Clinical Trial Enrollment

Clinical Trial Update

Clinical Trial Agreement wi...

Shelf Registration Statemen...

Clinical Trial Participation

Securities Purchase Agreements

FDA Approval for Clinical T...

Collaboration Completion

Presentation Materials

Entry into a Material Defin...

Addition of Clinical Resear...

Reinstatement of Fees and C...

Investment Options Exercise

Collaboration Agreement

Other Special Situation

Disruption of Operations

Appointment of Chief Medica...

Compensation Reinstatement

Trademark Granted

Annual Meeting of Stockholders

Positive Study Outcomes

Partnership with CRO

Manufacturing Agreement

Expansion of Global Team

Market Expansion

Announcement of Pre-Clinica...

Securities Purchase Agreements

Expansion of IP Portfolio

Securities Purchase Agreements

Announcement of Formative S...

Announcement of Human Trial...

Securities Purchase Agreement

Securities Purchase Agreement

Cost Restructuring and Pre-...

Preparations for First-In-H...

Animal Study Results

External Links:

On February 20, 2026, Microbot Medical Inc. adjusted compensation for key executives: Simon Sharon's salary to NIS 1,008,000, Rachel Vaknin's to NIS 756,000, and a special bonus of approximately $140,000 for CEO Harel Gadot. This filing reports on significant changes in management compensation.

AI Assistant

MICROBOT MEDICAL INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.